MONAS

Montelukast

Respiratory » Anti-Asthmatic » Anti-Inflammatory

 
 
 
 
 


Indication

Monas in indicated for the prophylaxis and chronic treatment of Asthma & for the symptomatic relief of Allergic Rhinitis.


Dosage and Administration

AgeDose
6 months– 6 years4 mg/day, in the evening
6 years– 15 years5 mg/day, in the evening
15 years and older10 mg/day, in the evening


Composition

Monas ® 10: Each film coated tablet contains Montelukast Sodium USP equivalent to 10 mg Montelukast.

Monas ® 5 OFT: Each Oroflash tablet contains Montelukast Sodium USP equivalent to 5 mg Montelukast.

Monas ® 4 OFT: Each Oroflash tablet contains Montelukast Sodium USP equivalent to 4 mg Montelukast.

Monas ® 5: Each Chewable tablet contains Montelukast Sodium USP equivalent to 5 mg Montelukast.

Monas ® 4: Each Chewable tablet contains Montelukast Sodium USP equivalent to 4 mg Montelukast.